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Abstract  
The aim of this study was to monitor chlamydial shedding patterns in clinically affected koalas before, during and 
following treatment using quantitative real-time PCR.  Swab samples were obtained from 14 koalas presented for  
treatment at the Australian Wildlife Hospital.  Four of these animals were followed over a period of eight to nine weeks.   
Primers were designed based on the consensus signature sequence of the 16S rRNA chlamydial gene.  Additional  
primers were designed based on the sequence of the koala beta actin gene and used to normalise chlamydial values when  
comparing results from different swab samples.  Chlamydial 16S rRNA gene copy number was highest in swab samples  
from clinically affected sites.  Daily injections of chloramphenicol resulted in a marked and rapid reduction in the  
numbers of chlamydiae being shed from all sites.  In general chlamydial copy number was no longer detectable by the  
end of the second week of treatment.  No evidence of relapse of infection was detected at two weeks after the cessation  
of treatment.  In contrast, topical chloramphenicol treatment of the eyes required a longer treatment period and had little 
effect on the shedding of chlamydiae from other sites of the body.  Further studies are required to confirm the efficacy of  
a shorter treatment period.  
Keywords:   chlamydiae, koala, real time PCR, shedding, treatment  
* Manuscript
 2 
Introduction  
In the koala (Phascolarctos cinereus), chlamydiae have been associated with keratoconjunctivitis (Cockram and  
Jackson, 1974; Hemsley and Canfield, 1997) as well as genital (Brown and Grice, 1984; Higgins et al., 2005; McColl et  
al., 1984) and urinary tract infection (Brown and Grice, 1984; Brown et al., 1987; Hemsley and Canfield, 1997; Higgins  
et al., 2005). Both Chlamydophila pecorum and Cp. pneumoniae infect the koala (Girjes et al., 1988; Glassick et al., 
1996).  Chlamydial infection is considered to be widespread in most koala populations (Martin, 1985; Mitchell et al.,  
1988; Weigler et al., 1988; White and Timms, 1994) with published prevalence rates varying depending on the  
population studied and the method of detection used.  Using isolation in tissue culture, White and Timms (1994)  
reported a prevalence rate of 39 to 61% in south eastern Queensland.  The same study estimated the prevalence of  
clinical disease to be 15 to 20%. The polymerase chain reaction (PCR) assay has been well established as a sensitive and  
reliable method of detection of chlamydiae in the koala (Devereaux et al., 2003; Jackson et al., 1999).  Jackson et al.  
(1999) used DNA-based procedures for the detection and speciation of chlamydiae in two free-ranging koala  
populations in south eastern Queensland.  In one population the level of chlamydial infection was 85% with clinical  
disease apparent in 17% of animals.  The prevalence of infection in the second population was only 10% despite the  
presence of the same genotype of Cp. pecorum in the two populations.  Out of a total of 24 koalas infected with Cp.  
pecorum, five had evidence of clinical disease while none out of seven infected with Cp. pneumoniae showed any signs  
of disease.  Using DNA sequence analysis of the variable domain IV of the major outer membrane protein (MOMP)  
gene, Jackson et al. (1997) separated 15 koala Cp. pecorum isolates into five genetically distinct groups.  In addition,  
sequencing of part of the 16S rRNA gene has indicated that infections also occur with a genetically diverse array of  
chlamydiae distinct from any of the established chlamydial species (Devereaux et al., 2003).   
Chlamydial infections in the koala have been estimated as ranging from low to high grade based on the  
intensity of staining following amplification and DNA probe hybridization (Jackson et al., 1999), but actual levels of  
infection in the koala have not been quantified accurately to date.  Despite the large number of free-ranging koalas  
presented to wildlife facilities for treatment of chlamydiosis, particularly in south east Queensland (G. Gipp, personal  
communication; Environmental Protection Agency, 2005), there are no detailed reports of treatment regimes or efficacy  
in the scientific literature. Nottidge (2002) reported an absence of clinical signs in two free-ranging koalas seven months  
after release back into the wild following treatment of severe bilateral keratoconjunctivitis.  The treatment regime  
included systemic therapy with chloramphenicol as well as topical therapy with ophthalmic preparations containing  
chloramphenicol and corticosteroids.  However, that study did not seek to determine shedding of chlamydiae following  
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treatment.  The aims of the current study were to utilise real-time PCR to quantify the shedding of chlamydiae in  
animals presenting with a range of clinical backgrounds at a wildlife hospital and to determine the effect of treatment on  
shedding over a period of several weeks.  
  
Materials and Methods  
Animals  
Swab samples were obtained from five clinically normal koalas at Lone Pine Koala Sanctuary, Brisbane.  Swab samples  
were also obtained from 14 free-ranging koalas presented for treatment at the Australian Wildlife Hospital, Beerwah,  
Australia (Table 1). An indication of the age of the animals was obtained by assessing the amount of wear on the  
premolar and molar teeth of an individual (White and Kunst, 1990).  The animals were generally presented to the  
wildlife hospital by concerned members of the public or by wildlife rehabilitation volunteers. Reasons for presentation  
were bad condition, disease and trauma (i.e. vehicle collision and dog injury).  After a detailed clinical examination,  
animals could be divided into three subgroups based on different clinical presentations:   
Group 1 Ophthalmic disease, unilateral or bilateral kerato-conjunctivitis characterized, most commonly, by copious  
mucopurulent discharge, and varying degrees of conjunctival proliferation (granulation), keratitis and  
palpebral scarring (koalas 1, 2, 3, 12 and 14)   
Group 2 Urine staining of the rump (“dirty tail” or “wet bottom”) as a result of chronic cystitis (koalas 4, 5, 6, 7, 8,  
9, 10, 11)  
Group 3 Ophthalmic disease and urine staining of the rump (koala 13)  
  
Ophthalmic and urinary tract disease were generally quite obvious by external clinical signs. In contrast, reproductive  
tract disease in female koalas was most commonly diagnosed after anaesthesia by palpation or ultrasound detection of  
reproductive tract cysts or by the presence of a severe, bilateral open pyometron.  
Treatment  
Koalas 1, 2, 4, 7, 8, and 13 were considered on clinical grounds to be suitable for treatment and rehabilitation. Koalas 3,  
5, 6, 9, 10, 11, 12, 14 had lesions sufficient to justify euthanasia on humane grounds.  With the exception of one case  
(koala 1) in which a single injection of chloramphenicol was administered followed by topical eye treatments only as  
described below, koalas with clinical signs of chlamydiosis were treated with subcutaneous injections of  
chloramphenicol 150mg/ml (Chloramphenicol 150, Delvet Pty. Ltd., New South Wales, Australia) at a dose rate of  
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60mg/kg once each day for 45 days.  Koalas with keratoconjunctivitis were treated by bathing of eyes to remove  
exudate, then twice daily topical application of an eye ointment containing chloramphenicol 10mg/g and hydrocortisone  
acetate 5mg/g (Chloroptsone Eye Ointment, Delvet Pty. Ltd., New South Wales, Australia) and twice daily application  
of eye drops containing dexamethasone 1mg/ml (Maxidex 0.1%, Alcon Laboratories, Australia). Koalas with cystitis  
were treated with regular rump washing and a variety of antibiotics for secondary infections as indicated by culture and  
sensitivity testing.  
Sampling procedures  
Samples were collected from four of the animals (koalas 1, 7, 8 and 13) during the course of their treatment initially  
every three days and then weekly and finally fortnightly over a period of 8 to 9 weeks.  The final sample was obtained  
two weeks following the cessation of treatment.  In the case of a further two animals, samples were obtained up till day 6  
(koala 2) and day 9 (koala 4) post admission respectively. One koala (koala 9) was sampled on two occasions before her  
euthanasia for humane reasons. The remaining seven koalas were sampled only once and were then euthanized on  
humane grounds at the time of clinical examination because of the severity of disease and consequently poor prognosis.   
Animals were anaesthetized each time sampling occurred by intramuscular injection of alfaxalone 10mg/ml  
(Alfaxan CD RTU®, Jurox New Zealand) at a dose rate of 3mg/kg.  Anaesthesia was maintained by inhalation with a  
mixture of isoflurane and oxygen administered to effect by mask or endotracheal tube. Up to nine swabs per sampling  
event were collected from different sites using sterile aluminium-shafted fine cotton-tipped swabs (Copan, Italy).  All or  
some of the following sites were swabbed: left eye exudate, right eye exudate, left conjunctiva, right conjunctiva, left  
and right nasal cavity (pooled), oropharynx, urogenital sinus (females), penile urethra (males), rectum and urine  
sediment.  Swabs of urine sediment were obtained by centrifugation of up to 1.5 ml of urine, removal of supernatant and  
swabbing of the resultant pellet. In some cases, urine was collected by cystocentesis, in others by manual expression of  
the bladder.  In some cases, particularly if cystitis was present, urine was unable to be obtained because the bladder was  
empty.   
Isolation of DNA and real time PCR  
The swab samples were stored at -70°C until the DNA was extracted as described by Devereaux et al. (2003).  Briefly,  
one ml of sucrose phosphate glutamine (SPG) was added to each swab and vortexed vigorously.  Then 0.5 ml of the cell  
suspension was centrifuged at 13,000 x g for 30 min and the pellet resuspended in 40 µl of SPG before heating at 95°C  
for 10 mins.  The PCR mixture consisted of 1 µl of DNA template, 10 µl of 2X Sybr Green PCR Master Mix (Applied  
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Biosystems, Foster City, California), 250 nM concentrations (each) of the forward and reverse primers made up to a  
final volume of 20 µl with PCR-grade water.    
The 16S rRNA real time primers were designed using the consensus signature sequence published by Everett et  
al. (1999).  OLIGO Primer Analysis software (Molecular Biology Insights Inc., Cascade, Colorado) was used to assist in  
the selection of all primer sequences used in this study.  The primer pair 16S rt F (5’-GCTTGTTGGTGGGGTAA-3’)  
and  16S rt R (5’-CAGTGTTGGCGGTCAAT-3’) targeted a 72 base pair region of  the 16S rRNA gene.  
Standards of known concentration of 102, 104, 106 and 108 copy numbers of the target 16S rRNA gene sequence  
were prepared as follows.  DNA extracted from a known positive Cp. pecorum koala sample was amplified by PCR  
using the 16S rRNA gene real time primers.  The PCR product was electrophoresed in a 2% agarose/TBE (45 mM Tris- 
borate and 1 mM EDTA, pH 8.0) gel, stained with ethidium bromide (0.5 µg ml-1) and visualized with a UV  
transilluminator (λ = 302 nm).  The band was cut out of the gel and the DNA purified using the High Pure PCR Product  
Purification Kit (Roche, Applied Science, Germany) according to the manufacturer’s instructions.   The concentration of  
DNA in the purified preparations was determined by spectrophotometric measurement of absorbance at 260 and 280 nm  
wavelengths.  The number of molecules of product was calculated using Avogadroe’s formula.  
All reactions were carried out on an Applied Biosystems 7000 SDS real-time PCR machine (Applied  
Biosystems, Foster City, California).  Following an initial incubation of 95°C for 10 min to activate the DNA  
polymerase, 40 cycles of 10 sec at 95°C and 30 sec at 60°C were carried out followed by a final dissociation stage.   
DNA samples from a known Cp. pecorum infected koala and from a known Cp. pneumoniae infected koala were used as  
positive controls while water was used as a negative control.  All the samples were tested in triplicate.  
On account of the varying amounts of clinical material obtained by this method of sampling and to facilitate  
comparisons between the results obtained from different swab samples, samples were also tested in triplicate for the  
presence of the koala beta-actin gene (separate wells on the same 96 well plate being used to test for the presence of  
chlamydial 16S rDNA).  DNA samples from a cloned portion of the koala beta-actin gene and water were used as  
positive and negative controls, respectively.  The copy number was normalised by dividing the 16S rRNA gene copy  
number by the beta-actin gene copy number.  The beta-actin primers were designed from the koala beta-actin gene,  
accession number DQO58212.  The primer pair K beta-actin F (5'-TGCATCTAGCTCCTCTCTGG-3') and  K beta-actin  
R (5'-GCATCGGAACCTCTCGT-3') targeted a 82 base pair region of  the koala beta-actin gene.  Standards of known  
concentration of 102, 104, 106 and 108 copy numbers of the target beta-actin gene sequences were prepared as follows.   
DNA extracted from a nasal swab sample from a koala was amplified by PCR using the beta-actin primers and purified  
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using the Qiaex II Gel Extraction Kit (Qiagen Inc., Valencia, California) according to the manufacturer’s instructions .  
The purified product was cloned using the pGEM-T vector (Promega Corp., Madison, Wisconsin) in Escherichia coli  
JM109 cells according to the manufactuer’s instructions.   
Samples were considered positive for the presence of chlamydiae when a 16S rRNA gene copy number greater  
than one was present in the sample and the dissociation curve profile matched that of the positive controls.  In order to  
compare chlamydial copy number from one swab with another, the 16S rRNA gene copy number was divided by the  
corresponding beta-actin gene copy number to produce a normalised 16S rRNA gene copy number.    
16S rRNA gene sequencing  
Ten positive samples including both ocular and urogenital samples from eight different koalas (koalas 2, 4, 7, 8, 10, 12,  
13 and 14) were amplified using the 16S rRNA gene ‘signature sequence’ primers described by Everett et al. (1999) and  
sequenced by the dideoxynucleotide method (Sanger and Coulson, 1977). A 294 bp consensus sequence was generated  
from nucleotide sequence alignment of the 10 sequences obtained using CLUSTAL W (version 1.82;  
http://www.ebi.ac.uk; 21).  
  
Results  
Clinically normal animals  
One of the five was found PCR-positive for chlamydiae, but only in the urogenital tract swab, where 24 copies were  
detected.    
Clinically diseased and treated animals  
The results of the treated animals (Figure 1) have been grouped on the basis of their primary clinical presentation into  
one of three categories: ophthalmic disease, urogenital tract disease, and both ophthalmic and urogenital tract disease.  
With the exception of koala 12, female koalas with reproductive tract disease also had chronic cystitis, as evidenced by  
marked urine staining of the fur of the rump.   
Koalas presenting with ophthalmic disease only  
Chlamydial copy number was much higher in swabs from clinically affected eyes than in swabs from other sites.  Some  
shedding was detected in the nasal swabs from two animals but the chlamydial copy number was ≤ 20.  In contrast the  
oro-pharyngeal swabs were negative.  Chlamydial DNA was present in the urogenital and urine sediment swabs of  
animals presenting because of ophthalmic disease, but generally at much lower levels (ranging from 0 to 715 copy  
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number) than was detected in the swabs from the animals with urogenital tract disease.  Koala 2 was found to be PCR- 
positive for chlamydiae in the rectal swab.  
Koalas presenting with urogenital disease only:  
The urogenital and urine sediment swab samples from the animals with signs of urogenital tract disease contained very  
high chlamydial copy number with one urogenital swab sample containing 8.64 x 107 per swab, the highest amount  
recorded during the study.  The rectal swabs were PCR-positive in some of the animals.   
Koalas presenting with both ophthalmic and urogenital tract disease  
Chlamydial copy number was high in both ocular and urogenital swabs in animals presenting with both conjunctivitis  
and urogenital tract disease.  One eye swab contained 1.02 x 107 copy number per swab, the highest level observed in  
any eye swab over the course of the study.  The chlamydial copy number was relatively high in the rectal swabs from  
three of the four animals in this group.  
Normalised 16S rRNA gene copy number  
The concurrent beta-actin gene assay confirmed the presence of host cells on swabs.  For 91% of samples (86 out of 95  
samples tested) koala host cells were evident in the test sample, however, in the other nine samples tested the absence of  
any beta-actin copy number suggested little or no clinical material had been obtained during the swabbing process.  In  
addition, the successful amplification of the beta-actin gene demonstrated in several cases that 16S rRNA gene-negative  
samples were negative due to absence of chlamydial DNA rather than due to the presence of inhibitors to the reaction.   
Normalisation of the 16S rRNA copy number tended to result in significantly increased values for urinary sediment  
swabs compared with results from other sites.  This effect occurred whether the samples were taken from animals with  
ocular infections or from animals with urogenital tract infection (results not shown).  
Response to treatment  
In most of the treated animals the shedding of chlamydiae was no longer detectable by the end of the second week of  
treatment.  Occasional increases in chlamydial copy number occurred subsequently but these were generally of a low  
level and of short duration (Figure 2). Chlamydial shedding by koala 13 was dramatically reduced by day 13 of  
antibiotic therapy at all sites and remained negative for the rest of the observation period except for a temporary, small  
rise in copy number in the nasal sample at day 20.  In contrast, in the case of koala 1 (Figure 3) chlamydial copy number  
remained at a significant level in the urogenital swab samples and also increased for a period in the right eye and rectal  
samples.  This is probably due to the fact that this animal received only one injection of chloramphenicol and was  
principally treated topically.   
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16S rRNA gene sequencing  
All ten chlamydial isolates sequenced in this study were the same genotype. BLAST analysis of the GenBank database  
gave highest similarity with Cp. pecorum 16S rRNA gene sequences and a perfect match with 5 of 11 Cp. pecorum 16S  
rRNA gene sequences compared with in the database.    
  
Discussion  
Chlamydial infection is considered to be the most important cause of disease in the koala (Brown and Grice, 1984;  
Brown et al., 1987) with infection being widespread in many koala populations (Jackson et al., 1999; White and Timms,  
1994).  This is the first study to apply real-time PCR to the determination of the shedding patterns of chlamydiae in  
naturally infected wild koalas and to the assessment of the efficacy of antibiotic therapy on chlamydial infection in those  
animals.    
Chlamydial 16S rRNA gene copy number reflected clinical presentation in most cases, being high in the swab  
samples from clinically affected sites.  This was particularly well illustrated in the case of unilateral eye infections.  In  
general, higher levels of chlamydial DNA were detected in urogenital and urinary sediment swab samples than in ocular  
swab samples.  It is possible that this is simply a reflection of the numbers of host cells available for infection.  If an  
arbitrary figure of 300 chlamydial particles is assigned to a typical chlamydial inclusion and if each beta-actin gene  
detected represents a single host cell, it was estimated that a peak infection rate of 1:5 host cells occurred in the urinary  
tract, 1:30 host cells in the lower urogenital tract  and 1:300 host cells in the eye.   
Chlamydial copy number in urogenital swab samples was frequently mirrored by rectal swab samples from the  
same animal.  It is likely that the close anatomical relationship between the two orifices, commonly termed the cloaca,  
may have led to cross contamination of the samples.  The nasal and oro-pharyngeal samples were often negative, even in  
animals with ocular disease.  It was surprising that infection did not extend down the nasolachrymal duct to the nasal  
chamber.  A number of the oro-pharyngeal swabs were also negative for the beta-actin gene.  This could have been due  
to a failure to collect host cells.    
Detection of the beta-actin gene yielded a number of benefits by confirming the presence of clinical material on  
the swabs as well as confirming the absence of inhibitors to DNA amplification.  Normalisation of chlamydial copy  
number values has previously been used by Dean et al. (2005) to permit comparisons between serial ocular swabs from  
cats experimentally infected with Cp. felis.  In the present study, the normalisation of copy number values produced  
markedly raised values for the urinary sediment samples relative to those for all the other sites.  As a result, the  
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normalisation of values did not provide any additional value in the interpretation of results when comparing the results  
obtained for different sample sites at a particular time point.    
Successful treatment of koalas with chlamydial infection has traditionally been difficult due to factors such as  
the severity and chronicity of disease, presence of secondary infections and apparent immunodeficiency syndrome  
(Hanger, 1999).  In the present study, daily treatment with parenterally administered chloramphenicol resulted in a rapid  
reduction in the numbers of chlamydiae being shed from all sites.  The continued absence of chlamydial DNA in all  
samples obtained two weeks following the cessation of treatment, with the exception of koala Jada, strongly suggests  
that the treatment regime used was effective in clearing the chlamydial infection fully.  Among the advantages of the  
treatment regime used in this study is a single daily treatment eliminating the need to handle animals more than once a  
day.  Based on the results presented in this study it is likely that the duration of treatment could be reduced to 3 weeks  
without a loss of efficacy.  This contrasts with the situation in cats infected with Cp. felis where recent studies suggest  
that treatment should be continued for at least four weeks (Dean et al., 2005).  However, a previous study in cats  
indicated that a much shorter treatment duration is effective (Sykes et al., 1999).  Further studies are required to assess  
the risk of relapse in koalas treated for a shorter period of time.    
The finding that all of the positive-PCR samples sequenced were Cp. pecorum was not unexpected given the  
significantly higher prevalence rate of Cp. pecorum infection compared to Cp. pneumoniae in some free-range koala  
populations (Jackson et al., 1999).  In addition, the study by Jackson et al. (1999) found that Cp. pecorum infection was  
present in all koalas with clinical disease examined suggesting that Cp. pecorum may be the more pathogenic of the two  
species.  It is possible that mixed chlamydial infections may have been missed n this study as the primers used were not  
species specific and the PCR-products were not cloned prior to sequencing.  
  
Conclusion  
In conclusion, this is the first study to apply real-time 16S rRNA PCR to the study of chlamydial infection in the koala.   
Chlamydiae are shed in large numbers from the urogenital tract and the conjunctivae of clinically affected koalas.  Use  
of a second primer set to detect the koala beta-actin gene served as a useful external control, confirming the presence of  
adequate clinical material and the absence of inhibitors to the amplification reaction.  Antibiotic therapy rapidly reduced  
the level of infection with parenteral treatment effectively eliminating the infection from all sites after approximately  
two weeks of treatment in most cases.  Topical ocular treatment had little effect on chlamydial shedding from sites other  
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than the eyes.  Further studies of this nature are required to assess other therapeutic regimes in koalas and to confirm the  
efficacy of a shorter treatment duration.  
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Table 1   Details of history and clinical findings in 14 diseased koalas treated at the Australian Wildlife Hospital.  
  
  
Figure 1    Mean chlamydial 16S rRNA gene copy number in koalas with ophthalmic disease (Group 1), koalas with  
urogenital tract disease (Group 2) and koalas with both ophthalmic and urogenital tract  disease (Group 3) (log scale).  
Rt. = right; Urogen. = urogenital tract; Urin. Sed. = urinary sediment.  
  
Figure 2   Serial shedding pattern of chlamydiae by koala 13 during full course of treatment (log scale).  
Rt. = right; Urogen. = urogenital tract; Urin. Sed. = urinary sediment.  
  
Figure 3   Serial shedding pattern of chlamydiae by koala 1 during full course of treatment (log scale).  
Rt. = right; Urogen. = urogenital tract; Urin. Sed. = urinary sediment.  
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Table 1   Details of history and clinical findings in 14 diseased koalas treated at the Australian 
Wildlife Hospital. 
 
Animal Sex/Age History/Clinical signs 
 
1 
 
 
 
Female 
4 yr 
 
Dog attack, no puncture wounds detected.  Mild unilateral conjunctivitis (left 
eye), single injection of chloramphenicol followed by topical treatment only.  
Good body coat, no pouch young, no abnormalities on ultrasound. Admitted 
for treatment. 
 
2 Male 
5 yr 
 
Bilateral kerato-conjunctivitis. Admitted for treatment. 
3 
 
Male 
3 yr 
Proliferative kerato-conjunctivitis of right eye.  Poor body condition.  Severe 
aplastic anaemia, thrombocytopenia, leukopenia (myelodysplastic syndrome, 
blast cells predominate in bone marrow). Euthanasia.  
 
4 
 
 
Female 
3 yr 
Dirty tail. Severe chronic cystitis (large numbers of cocci in urine sediment).  
No ocular disease and no palpable or ultrasonic evidence of reproductive 
tract disease. Admitted for treatment. 
 
5 
 
 
Female 
4 yr 
Marked dirty tail but cloaca okay.  Slight discoloration of fur around left eye 
but no exudate.  Large reproductive tract cyst palpable. Euthanasia. 
 
6 
 
Male 
3 yr 
 
Severe dirty tail and bilateral markedly dilated ureters. Euthanasia. 
 
7 
 
Male 
2 yr  
 
Severe dirty tail. Marked thickening of bladder wall. Admitted for treatment.  
 
8 
 
 
Female 
3 yr 
Poor body condition.  Severe dirty tail, chronic cystitis.  Marked thickening 
and spasm of bladder wall.  Mild dilatation of right ureter but no detectable 
reproductive pathology. Admitted for treatment. 
 
9 
 
Female 
2 yr 
Poor body condition, dirty tail.  Chronic cystitis and severe reproductive tract 
disease (pyometron). Euthanasia. 
  
10 
 
Female  
8 yr 
Chronic dirty tail. Poor body condition. Large, multiple reproductive tract 
cysts. Euthanasia. 
 
11 
 
Female 
8 to 12 yr 
Severe, chronic dirty tail.  Dilated right ureter and poor body condition. No 
reproductive tract cysts palpable. Very poor body condition. Euthanasia. 
 
12 
 
Female 
4 yr 
Severe bilateral keratoconjunctivitis  Reproductive tract cysts detected.  No 
evidence of cystitis. Euthanasia. 
 
13 
 
Male 
5 yr 
Hit by a car, but mild injuries.  Bilateral kerato-conjunctivitis and dirty tail. 
Admitted for treatment.  
 
14 
 
 
Male 
5 yr 
Poor body condition, thoracic scoliosis, cystitis, bilateral severe kerato-
conjunctivitis, mild stomatitis/pharyngitis and periodontal disease.  Mild 
cystitis (no dirty tail but evidence in urine sediment of neutrophils and 
bacteria). Euthanasia 
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